Can a new immune system fix T-Cell diseases? trial tests donor transplants
NCT ID NCT03663933
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a stem cell transplant from a healthy donor can safely treat people with severe T-cell problems. Participants receive chemotherapy and antibody therapy before the transplant, followed by donor stem cells. The goal is to see if the new immune system can control the disease, but ongoing management may still be needed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE LYMPHOPROLIFERATIVE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
-
National Marrow Donor Program
Minneapolis, Minnesota, 55401, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Strumming for the brain: could ukulele lessons sharpen minds in MS?
- Could a metabolic modulator help people with type 1 diabetes use insulin better?
- Supercharged immune cells aim to stop lymphoma comeback
- New IVIG aims to slash infection risk for immune-deficient patients
- New drug shows promise for kidney disease patients
- CRISPR's diabetes cell therapy trial ends early